Etiracetam
- Level
- Commodity
- Parent
- 51141500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51141560This classification denotes an anticonvulsant agent with the molecular formula C8H14N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 230447L0GL, chemically known as 1-pyrrolidineacetamide, alpha-ethyl-2-oxo-, (s)- but generally known as etiracetam, which bears US NIH Compound Identifier 59708. European Medicines Agency schedules Etiracetam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07308MIG. The term ETIRACETAM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 33, No. 10 1979, List 19). ETIRACETAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule etiracetam under HS 29337900 and SITC 51561. As of Q4 2014, ETIRACETAM remains the US FDA Preferred Term for this commodity. Etiracetam bears US NLM identifiers UMLS ID C0059859 and NCI Concept Code C78002. SMILES: O=C1N(CCC1)C(CC)C(=O)N.
Same parent
Under 51141500 · 80Activities that produce or sell this
KBLI · 8Inherited from family 51140000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.